Navigation Links
Lilly Confirms Date and Conference Call for Third-Quarter 2017 Financial Results Announcement
Date:10/2/2017

INDIANAPOLIS, Oct. 2, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the third quarter of 2017 on Tuesday, October 24, 2017. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will begin at 9 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/events.cfm. A replay will also be available on the website following the conference call.

About Eli Lilly and Company Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. F-LLY

Refer to: Lauren Zierke; lauren_zierke@lilly.com; (317) 277-6524 (Media) Phil Johnson; johnson_philip_l@lilly.com; (317) 655-6874 (Investors)

View original content with multimedia:http://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-third-quarter-2017-financial-results-announcement-300529057.html


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. IHC 2017: Lillys Lasmiditan Significantly Reduces Pain in Patients with Migraine
2. Lilly Takes Steps to Streamline Business, Invest in New Medicines and Drive Growth
3. Lilly to Present New Data for Galcanezumab and Lasmiditan at the 18th Congress of the International Headache Society (IHC)
4. Lilly Reaches Settlement Agreement in U.S. Cialis Patent Litigation
5. Lillys Galcanezumab Significantly Reduces Number of Migraine Headache Days for Patients with Migraine: New Results Presented at AHS
6. IDF, in partnership with Lilly, announces second phase of BRIDGES programme funding for translational research in diabetes with focus on secondary prevention
7. Lilly Builds Upon Body of Data for Abemaciclib with Phase 3 MONARCH 2 Data Demonstrating Superior Progression-Free Survival in Advanced Breast Cancer
8. Lilly Confirms Date and Conference Call for First-Quarter 2017 Financial Results Announcement
9. Eli Lilly Partnering Deals and Alliances 2010 to 2017
10. Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017
11. Lilly and the William Sansum Diabetes Center announce a five-year research collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2019)... ... May 24, 2019 , ... ... are powerful in-line conveyors that transport high volumes of material through ordinary ... the benefits of 316SS including excellent chemical and corrosion resistance, performance in high ...
(Date:5/24/2019)... ... May 24, 2019 , ... Gym Source announced support for Global Wellness ... store on Saturday, June 8th. “The best way to improve health and wellness ... continued, “Active adults produce active children, and active children become active adults. It’s ...
(Date:5/23/2019)... ... May 24, 2019 , ... Post-Market ... Do To Comply with Agency Rules, Avoid Liability, and Implement Best Practices, **Law ... Thursday, June 28, 2019, https://www.fdanews.com/postmarketsurveillance , Early bird pricing for Post-Market ...
Breaking Medicine Technology:
(Date:5/23/2019)... ... May 23, 2019 , ... Hoban Law Group is proud to ... Legal Campaign. “It is essential to help educate the public about the most sweeping ... better place to do so than Times Square,” said Hoban Law Group Founder & ...
(Date:5/23/2019)... CHICAGO (PRWEB) , ... May 23, 2019 , ... ... the eye's lens, which blocks or changes the passage of light into the eye. ... declared June as Cataract Awareness Month to educate the public on risk factors, symptoms ...
(Date:5/23/2019)... Mass. (PRWEB) , ... May 23, 2019 , ... ... the healthcare industry, today announced that Lean Human Capital has selected the winners ... ninth year Lean Human Capital by HealthcareSource has recognized excellence in healthcare recruitment. ...
(Date:5/22/2019)... ... 2019 , ... 5 Design Change Considerations to Stay Compliant , An FDAnews ... , Do devicemakers read the fine print when changing a design? , Changes are ... all the t’s may result in inspection failures as well as missed profit opportunities. ...
(Date:5/22/2019)... INDIANAPOLIS (PRWEB) , ... May 22, 2019 , ... With record-breaking starting positions, three drivers ... and Ed Jones have qualified their Chevrolets for the team’s entry in the ... of the NTT IndyCar Series qualifying run, Pigot was sitting in pole position in his ...
Breaking Medicine News(10 mins):